Similar articles

• Long-term trial of fluphenazine decanoate and flupenthixol decanoate for cataleptic activity and effect on motor activity in rats.

  Chandra O, Bernard J, Matussek N. Chandra O, et al. Arzneimittelforschung. 1974 Nov;24(11):1821-4. Arzneimittelforschung. 1974. PMID: 4480057 No abstract available.
• The central effects of scopolamine in man.

  Safer DJ, Allen RP. Safer DJ, et al. Biol Psychiatry. 1971;3(4):347-55. Biol Psychiatry. 1971. PMID: 4950489 Review. No abstract available.
• Depot fluphenazine: risk/benefit ratio.

  Glazer WM. Glazer WM. J Clin Psychiatry. 1984 May;45(5 Pt 2):28-35. J Clin Psychiatry. 1984. PMID: 6370986 Review.
• Apparent transient effects of recent "ecstasy" use on cognitive performance and extrapyramidal signs in human subjects.

  Smith RM, Tivarus M, Campbell HL, Hillier A, Beversdorf DQ. Smith RM, et al. Cogn Behav Neurol. 2006 Sep;19(3):157-64. doi: 10.1097/01.wnn.0000213909.41901.cc. Cogn Behav Neurol. 2006. PMID: 16957494
• Relationship between the behavioral and electroencephalographic effects of chlorpromazine and fluphenazine in rats.

  Babbini M, Gaiardi M, Bartoletti M. Babbini M, et al. Pharmacology. 1975;13(6):520-5. doi: 10.1159/000136946. Pharmacology. 1975. PMID: 1221434